{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:00:30Z","timestamp":1790254830829,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["GR004596-1"],"award-info":[{"award-number":["GR004596-1"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pars plana vitrectomy (PPV) for symptomatic vitreous opacities, commonly referred to as floaterectomy, is an increasingly performed elective procedure that can meaningfully improve quality of life. However, like all intraocular surgery, it carries the risk of endophthalmitis. To our knowledge, only 2 cases of this complication following floaterectomy have previously been reported. The purpose of this study is to report the largest series of acute-onset bacterial endophthalmitis following floaterectomy, characterizing clinical presentation, causative organisms, antibiotic susceptibilities, histopathology, and visual outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective, interventional case series conducted at a tertiary referral center. A query of all patients who underwent PPV for vitreous opacities from January 2010 through December 2025 was performed. Patients were included if they developed acute-onset endophthalmitis (within one month of PPV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five eyes of 5 patients were included. Two of 394 patients (0.5%) who underwent floaterectomy at our institution developed acute-onset endophthalmitis; 3 additional cases were referred from outside retina specialists. Mean presenting BCVA was 2.1 logMAR (~\u200920\/2500). Four of 5 vitreous cultures (80%) were positive: 2 gram-positive (\n                      <jats:italic>Staphylococcus caprae<\/jats:italic>\n                      ,\n                      <jats:italic>Staphylococcus lugdunensis<\/jats:italic>\n                      ) and 2 gram-negative (\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      ,\n                      <jats:italic>Serratia marcescens<\/jats:italic>\n                      ). The institutional endophthalmitis rate of 0.5% was not statistically different from published post-PPV rates of 0.16\u20130.28% (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.13). Visual outcomes were polarized: 3 of 5 eyes (60%) achieved BCVA\u2009\u2265\u200920\/80, while 2 of 5 (40%) progressed to no light perception and underwent enucleation, both involving gram-negative organisms. Histopathology in one enucleated eye demonstrated extensive intraocular necrosis and suppurative inflammation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Acute-onset endophthalmitis following floaterectomy is rare, occurring at a rate statistically similar to PPV for other indications. However, given that floaterectomy is elective surgery for a largely benign, non-vision-threatening condition, the harm-to-benefit ratio is inherently less favorable than PPV performed for sight-threatening pathology. Gram-negative infections were associated with catastrophic and irreversible vision loss, including enucleation. These findings underscore the importance of thorough, candid preoperative counseling regarding the risk of severe infectious complications before proceeding with floaterectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00877-4","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:36:03Z","timestamp":1783056963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute-onset endophthalmitis following pars plana vitrectomy for symptomatic vitreous opacities: a case series"],"prefix":"10.1186","volume":"12","author":[{"given":"Michael Y.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Kyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon J.","family":"Rohowetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis E.","family":"Margo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Fortun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Smiddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Harry W.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"877_CR1","doi-asserted-by":"publisher","unstructured":"Duke RCT, Fischer NA, Crosson JN, Albert MA, Feist RM, Mason JO. Long-term outcomes on quality of life following sutureless vitrectomy for symptomatic vitreous floaters. J Vitreoretin Dis. 2025. https:\/\/doi.org\/10.1177\/24741264251388103.\u00a0PubMed PMID: 41208950; PubMed Central PMCID: PMC12588966.","DOI":"10.1177\/24741264251388103"},{"issue":"4","key":"877_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3928\/23258160-20130715-14","volume":"44","author":"SG Schwartz","year":"2013","unstructured":"Schwartz SG, Flynn HW, Fisher YL. Floater scotoma demonstrated on spectral-domain optical coherence tomography and caused by vitreous opacification. Ophthalmic Surg Lasers Imaging Retina. 2013;44(4):415\u20138. https:\/\/doi.org\/10.3928\/23258160-20130715-14 . PubMed PMID: 23883538.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"5","key":"877_CR3","first-page":"391","volume":"121","author":"N Gill","year":"2024","unstructured":"Gill N, Singh A. Management of Visually Significant Vitreous Opacities. Mo Med. 2024;121(5):391\u20134. PubMed PMID: 39421475; PubMed Central PMCID: PMC11482840.","journal-title":"Mo Med"},{"issue":"12","key":"877_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.oret.2025.05.014","volume":"9","author":"SK Boneva","year":"2025","unstructured":"Boneva SK, Nguyen JH, Mamou J, Yee KM, Hoerig C, Silverman RH, et al. Clinical Management of Vision Degrading Myodesopsia from Vitreous Floaters: Observation vs. Limited Refractive Vitrectomy. Ophthalmol Retina. 2025;9(12):1149\u201358. https:\/\/doi.org\/10.1016\/j.oret.2025.05.014 . PubMed PMID: 40381842; PubMed Central PMCID: PMC12354178.","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"877_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/IAE.0000000000000063","volume":"34","author":"JO Mason","year":"2014","unstructured":"Mason JO, Neimkin MG, Mason JO, Friedman DA, Feist RM, Thomley ML, et al. Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters. Retina Phila Pa. 2014;34(6):1055\u201361. https:\/\/doi.org\/10.1097\/IAE.0000000000000063. PubMed PMID: 24384616.","journal-title":"Retina Phila Pa"},{"issue":"6","key":"877_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00006982-200011000","volume":"20","author":"WM Schiff","year":"2000","unstructured":"Schiff WM, Chang S, Mandava N, Barile GR. Pars plana vitrectomy for persistent, visually significant vitreous opacities. Retina Phila Pa. 2000;20(6):591\u20136. https:\/\/doi.org\/10.1097\/00006982-200011000. -00001 PubMed PMID: 11131410.","journal-title":"Retina Phila Pa"},{"key":"877_CR7","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2147\/OPTH.S67855","volume":"8","author":"CR Henry","year":"2014","unstructured":"Henry CR, Schwartz SG, Flynn HW. Endophthalmitis following pars plana vitrectomy for vitreous floaters. Clin Ophthalmol Auckl NZ. 2014;8:1649\u201353. https:\/\/doi.org\/10.2147\/OPTH.S67855.\u00a0PubMed PMID: 25210434; PubMed Central PMCID: PMC4155899.","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"5","key":"877_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41433-020-0825-0","volume":"34","author":"EO Zeydanli","year":"2020","unstructured":"Zeydanli EO, Parolini B, Ozdek S, Bopp S, Adelman RA, Kuhn F, et al. Management of vitreous floaters: an international survey the European VitreoRetinal Society Floaters study report. Eye Lond Engl. 2020;34(5):825\u201334. https:\/\/doi.org\/10.1038\/s41433-020-0825-0 . PubMed PMID: 32313173; PubMed Central PMCID: PMC7182575.","journal-title":"Eye Lond Engl"},{"issue":"9","key":"877_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaophthalmol.2024.2749","volume":"142","author":"BL VanderBeek","year":"2024","unstructured":"VanderBeek BL, Chen Y, Tomaiuolo M, Deaner JD, Syed ZA, Acharya B, et al. Endophthalmitis Rates and Types of Treatments After Intraocular Procedures. JAMA Ophthalmol. 2024;142(9):827\u201334. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.2749.","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"877_CR10","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/IAE.0000000000004537","volume":"45","author":"S Zafar","year":"2025","unstructured":"Zafar S, Dun C, Cai CX, Schein OD, Makary M, Woreta F. Endophthalmitis after retinal surgery: a 8-year medicare analysis. Retina Phila Pa. 2025;45(10):1908\u201315. https:\/\/doi.org\/10.1097\/IAE.0000000000004537.\u00a0PubMed PMID: 40456117.","journal-title":"Retina Phila Pa"},{"issue":"8","key":"877_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bjophthalmol-2013-304486","volume":"98","author":"JC Park","year":"2014","unstructured":"Park JC, Ramasamy B, Shaw S, Ling RHL, Prasad S. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: clinical presentation, microbiology, management and outcome. Br J Ophthalmol. 2014;98(8):1080\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304486 . PubMed PMID: 24686917.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"877_CR12","doi-asserted-by":"publisher","first-page":"e0191173","DOI":"10.1371\/journal.pone.0191173","volume":"13","author":"M Bhende","year":"2018","unstructured":"Bhende M, Raman R, Jain M, Shah PK, Sharma T, Gopal L, et al. Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital. PLoS ONE. 2018;13(1):e0191173. https:\/\/doi.org\/10.1371\/journal.pone.0191173 . PubMed PMID: 29338030; PubMed Central PMCID: PMC5770060.","journal-title":"PLoS ONE"},{"issue":"5","key":"877_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajo","volume":"138","author":"CWG Eifrig","year":"2004","unstructured":"Eifrig CWG, Scott IU, Flynn HW, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004;138(5):799\u2013802. https:\/\/doi.org\/10.1016\/j.ajo. 2004.06.035 PubMed PMID: 15531315.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"877_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.22038\/ijbms.2025.82302.17799","volume":"28","author":"P Arya","year":"2025","unstructured":"Arya P, Sharma V, Singh P, Thapliyal S, Sharma M. Bacterial endotoxin-lipopolysaccharide role in inflammatory diseases: An overview. Iran J Basic Med Sci. 2025;28(5):553\u201364. https:\/\/doi.org\/10.22038\/ijbms.2025.82302.17799 . PubMed PMID: 40666174; PubMed Central PMCID: PMC12258786.","journal-title":"Iran J Basic Med Sci"},{"issue":"6","key":"877_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/IAE.0000000000000469","volume":"35","author":"J Sridhar","year":"2015","unstructured":"Sridhar J, Kuriyan AE, Flynn HW, Miller D, Endophthalmitis caused by pseudomonas. aeruginosa: clinical features, antibiotic susceptibilities, and treatment outcomes. Retina Phila Pa. 2015;35(6):1101\u20136. https:\/\/doi.org\/10.1097\/IAE.0000000000000469.\u00a0PubMed PMID: 25658178.","journal-title":"Retina Phila Pa"},{"issue":"6","key":"877_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/IAE.0000000000000509","volume":"35","author":"J Sridhar","year":"2015","unstructured":"Sridhar J, Kuriyan AE, Flynn HW, Smiddy WE, Venincasa VD, Miller D. Endophthalmitis caused by serratia marcescens: clinical features, antibiotic susceptibilities, and treatment outcomes. Retina Phila Pa. 2015;35(6):1095\u2013100. https:\/\/doi.org\/10.1097\/IAE.0000000000000509.\u00a0PubMed PMID: 25741815.","journal-title":"Retina Phila Pa"},{"issue":"5","key":"877_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.oret.2017.08.025","volume":"2","author":"NA Yannuzzi","year":"2018","unstructured":"Yannuzzi NA, Patel NA, Relhan N, Tran KD, Si N, Albini TA, et al. Clinical features, antibiotic susceptibilities, and treatment outcomes of endophthalmitis caused by Staphylococcus epidermidis. Ophthalmol Retina. 2018;2(5):396\u2013400. https:\/\/doi.org\/10.1016\/j.oret.2017.08.025.","journal-title":"Ophthalmol Retina"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00877-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00877-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00877-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:03:47Z","timestamp":1790251427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00877-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00877-4","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this manuscript was obtained from the Institutional Review Board of the University of Miami, ensuring compliance with ethical guidelines and the protection of human subjects involved in the study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual patients for whom identifying information is included in this article.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm this publication is original.","order":4,"name":"Ethics","label":"Publication originality statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work, and have given their approval for this version to be published.","order":5,"name":"Ethics","label":"Authorship","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"131"}}